share_log

SAB Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Sessa Capital (Master), L.P.

SEC announcement ·  Nov 14, 2023 16:08
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more